About Unidrug Innovative Pharma Technologies Limited
Data last updated: 04 January 2026
Unidrug Innovative Pharma Technologies Limited is a public limited company based in Indore, Madhya Pradesh, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 13 March 1987, the company has been in operation for over 39 years.
Registered with ROC Gwalior under CIN U85120MP1987PLC003875.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹9.58 Cr. Formerly known as Uni Drug Ltd and Uni Drug Pvt Ltd. It is led by directors including Jainesh Jain and Gajanand Agrawal.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 84 A Sector – E Sanwer Road, Indore, Madhya Pradesh, India – 452015.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.46 Cr, a growth of 28% compared to the previous year.
The company has a workforce of approximately 33 employees as per the latest available data.
The company is associated with 1 brand - Unidrug. As per MCA filings, the company has open charges of ₹40.49 Cr and satisfied charges of ₹16.87 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unidrugindia.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social MediaLocked
-
Registered AddressPlot No. 84 A Sector – E Sanwer Road, Indore, Madhya Pradesh, India – 452015
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited has undergone 2 name changes throughout its history. The company was previously known as Uni Drug Ltd, and Uni Drug Pvt Ltd. The current legal name is Unidrug Innovative Pharma Technologies Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Unidrug Innovative Pharma Technologies Limited | Current |
| Uni Drug Ltd | Previous |
| Uni Drug Pvt Ltd | Previous |
CIN History of Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited has one previous CIN (Corporate Identification Number): L85120MP1987PLC003875. The current CIN is U85120MP1987PLC003875, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85120MP1987PLC003875 | Current |
| L85120MP1987PLC003875 | Previous |
Associated Brands with Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited operates one associated brand: Unidrug. These brands represent Unidrug Innovative Pharma Technologies Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| API development, manufacturing, and marketing with global exports from India. | unidrugindia.com |
Competitors & Alternatives of Unidrug Innovative Pharma Technologies Limited
Brands and companies operating in the same space as Unidrug Innovative Pharma Technologies Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Laurus Labs
|
Pharmaceutical and biotechnology company | Hyderabad, India, India | 2005 |
Symbiotec
|
Non-sterile steroid hormone-based APIs and intermediates are manufactured. | Indore, India, India | 2002 |
Beijing Biostar Technologies
|
APIs, intermediates, and biochemical reagents are developed and manufactured. | Beijing, China, China | 2002 |
Sterling Pharma Solutions
|
Contract development, manufacturing, and analytical services for APIs are offered. | Dudley, United Kingdom, United Kingdom | 2016 |
Provepharm Life Solutions
|
APIs and drug products are developed and valorized in pharmaceuticals. | Marseille, France, France | 1998 |
Hikal
|
APIs and intermediates are produced via custom synthesis and research. | Mumbai, India, India | 1988 |
Snapdragon Chemistry
|
Drug discovery and development service provider | Cambridge, United States, United States | 2014 |
SeQuent
|
APIs are developed and manufactured for therapeutic areas. | Bengaluru, India, India | 2002 |
Jubilant Pharma
|
Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | Noida, India, India | 1978 |
Business Activity of Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Unidrug Innovative Pharma Technologies Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited is audited by S N GADIYA & CO. for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S N GADIYA & CO. | Locked | Locked | Locked |
Complete auditor history for Unidrug Innovative Pharma Technologies Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited is currently managed by 4 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jainesh Jain | Managing Director | 20 Aug 1995 | 30 Years 11 Months | Current |
|
Gajanand Agrawal
Also directs:
Unidrug Innovative Pharma Technologies Limited
|
Director | 20 Sep 2018 | 7 Years 10 Months | Current |
| Bharat Jain | Director | 20 Sep 2018 | 7 Years 10 Months | Current |
|
Varsha Jain
Also directs:
Unidrug Innovative Pharma Technologies Limited
|
Director | 05 Oct 1995 | 30 Years 9 Months | Current |
Financials of Unidrug Innovative Pharma Technologies Limited FY 2025 filings available
Unidrug Innovative Pharma Technologies Limited reported revenue of ₹44.46 Cr (up 28.00% YoY) for FY 2025.
Ten-year financial statements for Unidrug Innovative Pharma Technologies Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Unidrug Innovative Pharma Technologies Limited
Shareholding and ownership data for Unidrug Innovative Pharma Technologies Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Unidrug Innovative Pharma Technologies Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Oct 2024 | Others | ₹15 Lakh | Open |
| 29 Jan 2024 | Others | ₹25 Lakh | Open |
| 21 Nov 2023 | Others | ₹15 Lakh | Open |
| 03 Jul 2020 | Others | ₹67 Lakh | Open |
| 28 Apr 2017 | Others | ₹39.27 Cr | Open |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited has a workforce of 33 employees as of Apr 04, 2024.
Employee and EPFO history for Unidrug Innovative Pharma Technologies Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Unidrug Innovative Pharma Technologies Limited
GST registrations and filing compliance for Unidrug Innovative Pharma Technologies Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Unidrug Innovative Pharma Technologies Limited
Credit ratings, litigation, and regulatory alerts for Unidrug Innovative Pharma Technologies Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unidrug Innovative Pharma Technologies Limited
MSME payment history for Unidrug Innovative Pharma Technologies Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unidrug Innovative Pharma Technologies Limited
Corporate group structure for Unidrug Innovative Pharma Technologies Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unidrug Innovative Pharma Technologies Limited
MCA filings and documents for Unidrug Innovative Pharma Technologies Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Unidrug Innovative Pharma Technologies Limited
Frequently Asked Questions about Unidrug Innovative Pharma Technologies Limited
Unidrug Innovative Pharma Technologies Limited is an active public limited company in the pharma sector based in Indore, Madhya Pradesh, India. It was incorporated on 13 March 1987 (39+ years old) and is registered under CIN U85120MP1987PLC003875. The company has 33 employees.
Unidrug Innovative Pharma Technologies Limited reported revenue of ₹44.46 Cr for FY 2025 (up 28.00% YoY).
The current directors of Unidrug Innovative Pharma Technologies Limited are:
- Jainesh Jain - Managing Director
- Gajanand Agrawal - Director
- Bharat Jain - Director
- Varsha Jain - Director
The primary industry of Unidrug Innovative Pharma Technologies Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Unidrug Innovative Pharma Technologies Limited can be reached at the registered office: Plot No. 84 A Sector – E Sanwer Road, Indore, Madhya Pradesh, India – 452015, or through the website unidrugindia.com.
The authorised capital is ₹20 Cr, and the paid-up capital is ₹9.58 Cr.